OTC Markets OTCPK - Delayed Quote USD

Kyowa Kirin Co., Ltd. (KYKOF)

Compare
15.00
+0.75
+(5.26%)
At close: January 10 at 3:00:00 PM EST
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for KYKOF

Recent News: KYKOF

View More
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting

Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
GlobeNewswire last month
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
PR Newswire last month
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Business Wire 2 months ago
Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis

Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis
PR Newswire 3 months ago
Kyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual Meeting

Kyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual Meeting
PR Newswire 3 months ago
New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphatemia (XLH)

New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphatemia (XLH)
PR Newswire 4 months ago
Kyowa Kirin to end distribution of Fareston (toremefine) in the United States

Kyowa Kirin to end distribution of Fareston (toremefine) in the United States
PR Newswire 4 months ago
Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region

Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region
PR Newswire 5 months ago
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC

Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
PR Newswire 6 months ago
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024

Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
PR Newswire 8 months ago
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome

First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
Business Wire 8 months ago
View More

Related Tickers

YPH.SG Astellas Pharma Inc
9.25
0.00%
 
ALPMY Astellas Pharma Inc.
9.47
-0.73%
 
LLY Eli Lilly and Company
799.90
+1.61%
 
NVO Novo Nordisk A/S
86.26
+0.72%